Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
denosumab
Amgen's Xgeva Wins EU Approval
Amgen's Xgeva Wins EU Approval
Yahoo/Zacks.com
Amgen
denosumab
Europe
GSK
Novartis
Xgeva
News
Amgen Pushes Ahead With "Son of Dmab" for Treating Bones
Motley Fool
AMG785
Amgen
denosumab
osteoporosis
News
Amgen Presents New XGEVA (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data at SABCS
Yahoo/PR NewsWire
Amgen
breast cancer
denosumab
Xgeva
News
One Drug, Two Names, Two Wildly Different Prospects
Motley Fool
Amgen
denosumab
Prolia
Xgeva
News
Amgen's Bone Drug Denosumab Cleared to Treat Fractures in Cancer Patients
Bloomberg
Amgen
cancer
denosumab
News
Amgen Drug May Block Some Breast Cancer, Studies Hint
Bloomberg
Amgen
breast cancer
denosumab
»
11 comments
News
Amgen gets rapid FDA review for denosumab
Yahoo/AP
Amgen
denosumab
FDA
Prolia
»
4 comments
News
Amgen drug gets priority review for bone cancer
Marketwatch
Amgen
bone cancer
denosumab
FDA
Prolia
»
5 comments
News
FDA Grants Priority Review Designation to Denosumab Biologics License Application for the Reduction of Skeletal Related Events in Advanced Cancer Patients
Yahoo/PR NewsWire
Amgen
denosumab
skeletal metastases
»
4 comments
News
Amgen Gets FDA Approval and SonoSite Has a New Frontier
Motley Fool
Amgen
denosumab
Prolia
SonoSite
ultrasound
»
2 comments
1
2
3
4
5
next ›
last »
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT